Inogen Swaps CEO, Closes Rotech Sale, Launches $20M Cost-Cut Program
INGN sits 25% above its 52-week low of $5.045.
Summary
Inogen named COO Andy Reding President and CEO, closed the Rotech rental divestiture, and launched a $20 million annualized cost reduction program alongside a $14.8 million Q3 loss from continuing operations.
Key Events · Executive and Board Changes · INGN
-
CEO Change: Reding Replaces Smith
Effective October 30, 2026, the board appointed COO Andy Reding President and CEO and a Class III director, succeeding Kevin Smith, whose employment ended that day. Reding's package includes a $700,000 base salary, a 100% target bonus, a $300,000 one-time cash bonus with a two-year clawback, and a planned 2027 award of 337,500 RSUs/PSUs.
-
Rotech Divestiture Closed
The sale of the U.S. oxygen rental business to Rotech Healthcare closed November 2, 2026, for an estimated aggregate price of up to approximately $24.8 million, payable in six installments and subject to post-closing reconciliation.
-
$20M Cost Reduction Program
The board approved a program expected to generate approximately $20 million of annualized savings, with about half realized in Q4 2026 and the rest through 2027, substantially complete by end-2027. The company cannot yet estimate the charges or cash costs.
-
Q3 Loss Widens on Impairment
Q3 2026 revenue from continuing operations was $77.2 million, down 2.4% year over year, and the GAAP loss from continuing operations was $14.8 million versus $3.6 million a year earlier, including a $10.559 million impairment charge. Cash and securities totaled $97.7 million with no debt.
Analysis · INGN · Industrial Applications And Services
The real story here is the $20 million annualized cost reduction program: Inogen is shrinking into a leaner device business after divesting its rental arm. The board replaced CEO Kevin Smith with COO Andy Reding effective October 30, 2026, the same week the Rotech rental-business sale closed and the company posted a $14.8 million quarterly loss from continuing operations. Roughly half of the savings are expected to land in Q4 2026. Until the charges are quantified, investors cannot tell how much of that $20 million survives to the bottom line, and the new CEO inherits a business guiding to a $7-8 million adjusted loss for 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INGN was trading at $6.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $179.7M. The 52-week trading range was $5.05 to $8.14. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.